Troglitazone: the lesson that nobody learned? Edwin A. M. Gale Editorial 16 December 2005 Pages: 1 - 6
How should HbA1c measurements be reported? F. GorusC. MathieuE. Gerlo Commentary 24 December 2005 Pages: 7 - 10
Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005 P. Rossing Review 09 December 2005 Pages: 11 - 19
Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis G. Dahlquist For Debate 14 December 2005 Pages: 20 - 24
Do HbA1c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus? A. KerssenH. W. de ValkG. H. A. Visser Short Communication 09 December 2005 Pages: 25 - 28
Diabetes mellitus and impaired fasting glucose in Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study E. A. CarterJ. W. MacCluerH. E. Resnick Article 21 December 2005 Pages: 29 - 35
The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes E. KoustaZ. EfstathiadouD. G. Johnston Short Communication 09 December 2005 Pages: 36 - 40
Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study D. A. LawlorG. Davey SmithS. Ebrahim Article 23 December 2005 Pages: 41 - 48
Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes R. N. GuzderW. GatlingC. D. Byrne Article 10 December 2005 Pages: 49 - 55
Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women A. JuutilainenS. LehtoM. Laakso Article 20 December 2005 Pages: 56 - 65
Use of antimicrobials and risk of type 1 diabetes in a population-based mother–child cohort A. KilkkinenS. M. VirtanenA. Reunanen Short communication 13 December 2005 Pages: 66 - 70
Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function L. B. NielsenH. B. MortensenHvidøre Study Group Short communication 23 November 2005 Pages: 71 - 74
Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes G. AndersenJ. OvergaardO. Pedersen Article 12 November 2005 Pages: 75 - 82
Increased vulnerability of newly forming beta cells to cytokine-induced cell death J. J. MeierR. A. RitzelP. C. Butler Article 02 December 2005 Pages: 83 - 89
Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes Z. AsgharD. YauM. B. Wheeler Article 15 December 2005 Pages: 90 - 99
Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice N. ShanmugamI. T. TodorovR. Natarajan Article 10 December 2005 Pages: 100 - 107
Expression and function of leukaemia inhibitory factor and its receptor in normal and regenerating rat pancreas S. De BreuckL. BaeyensL. Bouwens Article 21 December 2005 Pages: 108 - 116
Glucagon secretion in relation to insulin sensitivity in healthy subjects B. Ahrén Article 17 December 2005 Pages: 117 - 122
Insulin control of placental gene expression shifts from mother to foetus over the course of pregnancy U. HidenA. MaierG. Desoye Article 13 December 2005 Pages: 123 - 131
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects J. WesterbackaA. CornérH. Yki-Järvinen Article 16 December 2005 Pages: 132 - 140
Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects H. B. HoltS. H. WildC. D. Byrne Article 02 December 2005 Pages: 141 - 148
Pioglitazone increases non-esterified fatty acid clearance in upper body obesity S. ShadidM. D. Jensen Article 02 December 2005 Pages: 149 - 157
The in vivo effects of the Pro12Ala PPARγ2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank G. D. TanM. J. NevilleF. Karpe Article 17 December 2005 Pages: 158 - 168
Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin J. L. ChanV. StoynevaC. S. Mantzoros Article 09 December 2005 Pages: 169 - 173
The role of protein kinase B/Akt in insulin-induced inactivation of phosphorylase in rat hepatocytes S. AistonL. J. HampsonL. Agius Article 10 December 2005 Pages: 174 - 182
Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin R. PalanivelA. MaidaG. Sweeney Article 09 December 2005 Pages: 183 - 190
The effect of intrauterine environment and low glomerular number on the histological changes in diabetic glomerulosclerosis S. E. JonesK. E. WhiteS. M. Marshall Article 09 December 2005 Pages: 191 - 199
Visual acuity and perimetry as measures of visual function in diabetic macular oedema E. AgardhH. StjernquistB. Bengtsson Article 10 December 2005 Pages: 200 - 206
Rosiglitazone-associated pseudotumour cerebri S. DagdelenO. Gedik Research Letter 13 December 2005 Pages: 207 - 208
Activator protein-1 in epiretinal membranes of patients with proliferative diabetic retinopathy Y. MitamuraA. OkumuraT. Harada Research Letter 09 December 2005 Pages: 209 - 211
PPARGC1A mRNA levels of in vitro differentiated human skeletal muscle cells are negatively associated with the plasma oleate concentrations of the donors H. StaigerN. StefanH.-U. Häring Research Letter 10 December 2005 Pages: 212 - 214
Comment on: Biason-Lauber A, Boehm B, Lang-Muritano M, et al (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905 D. -G. GengS. -Y. LiuJ. -X. She Letter 16 December 2005 Pages: 215 - 216
To: Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48:1247–1257 M. SnijderR. van DamP. Lips Letter - comment 13 December 2005 Pages: 217 - 218
We thank those who have given their time to referee for Diabetologia, all of whom are listed on our website. Special thanks are due to our key referees, listed below, who have each provided at least three timely and well-rated reports over the past year. List of referees 26 January 2006 Pages: 219 - 220